Urinary tract infections revisited

Kidney International

Volumn 71, Issue 8, 2007, Pages 721-723

  Godaly, G ^a   Svanborg, C ^a  

^a LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT;

ACUTE PYELONEPHRITIS; BACTERIAL COLONIZATION; BACTERIAL STRAIN; BACTERIAL VIRULENCE; CLINICAL PRACTICE; FIMBRIA; HOST RESISTANCE; HUMAN; IMMUNE RESPONSE; NONHUMAN; PRIORITY JOURNAL; REVIEW; URINARY TRACT INFECTION; UROPATHOGENIC ESCHERICHIA COLI;

EID: 34247244257     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002170     Document Type: Note

References (35)

1. Godaly G, Otto G, Burdick MD et al. Fimbrial lectins influence the chemokine repertoire in the urinary tract mucosa. Kidney Int 2007; 71: 778-786.
2. Tseng CC, Huang JJ, Wang MC et al. PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys. Kidney Int 2007; 71: 764-770.
3. Mabeck CE, Ørskov F, Ørskov I. Escherichia coli serotypes and renal involvement in urinary-tract infection. Lancet 1971; 1: 1312-1314.
4. Johnson J. Virulence factors in Escherichia coli urinary tract infection. Clin Microbiol Rev 1991; 4: 80-128.
5. Hacker J, Kaper JB. Pathogenicity islands and the evolution of microbes. Annu Rev Microbiol 2000; 54: 641-679.
6. Trifillis A, Donnenberg M, Cui X et al. Binding to and killing of human renal epithelial cells by hemolytic P-fimbriated E. coli. Kidney Int 1994; 46: 1083-1091.
7. Svanborg C, Bergsten G, Fischer H et al. Uropathogenic Escherichia coli as a model of hostparasite interaction. Curr Opin Microbiol 2006; 9: 33-39.
8. Svanborg C, Godaly G, Hedlund M. Cytokine responses during mucosal infections: role in disease pathogenesis and host defence. Curr Opin Microbiol 1999; 2: 99-105.
9. Seed P, Hultgren S. Blueprinting the regulatory response of Escherichia coli to the urinary tract. Trends Microbiol 2005; 13: 246-248.
10. Bergsten G, Samuelsson P, Wullt B et al. PapG-dependent adherence breaks mucosal inertia and triggers the innate immune response. J Infect Dis 2004; 189: 1734-1742.
11. Väisänen-Rhen V, Elo J, Väisänen E et al. P-fimbriated clones among uropathogenic Escherichia coli strains. Infect Immun 1984; 43: 149-155.
12. Leffler H, Svanborg-Edén C. Chemical identification of a glycosphingolipid receptor for Escherichia coli attaching to human urinary tract epithelial cells and agglutinating human erythrocytes. FEMS Microbiol Lett 1980; 8: 127-134.
13. Connell H, Agace W, Klemm P et al. Type 1 fimbrial adhesion enhances Escherichia coli virulence for the urinary tract. Proc Natl Acad Sci USA 1996; 93: 9827-9832.
14. Mulvey MA, Schilling JD, Hultgren SJ. Establishment of a persistent Escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun 2001; 69: 4572-4579.
15. Hedlund M, Frendeus B, Wachtler C et al. Type 1 fimbriae deliver an LPS- and TLR4-dependent activation signal to CD14-negative cells. Mol Microbiol 2001; 39: 542-552.
16. Schilling JD, Martin SM, Hunstad DA et al. CD14-and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect Immun 2003; 71: 1470-1480.
17. Ørskov F, Ferencz A, Ørskov I. Tamm-Horsfall protein or uromucoid is the normal urinary slime that traps type 1 fimbriated Escherichia coli. Lancet 1980; 1 (8173): 887.
18. Sharon N. Bacterial lectins, cell-cell recognition and infectious disease. FEBS Lett 1987; 217: 145-157.
19. Romih R, Korosec P, de Mello W Jr. et al. Differentiation of epithelial cells in the urinary tract. Cell Tissue Res 2005; 320: 259-268.
20. Bergsten G, Schembri M, Wullt B et al. A fimbrial paradox: effects on bacterial persistence and innate immunity in the human urinary tract. Mol Microbiol 2007 (in press).
21. Hagberg L, Engberg I, Freter R et al. Ascending, unobstructed urinary tract infection in mice caused by pyelonephritogenic Escherichia coli of human origin. Infect Immun 1983; 40: 273-283.
22. Holden N, Totsika M, Mahler E et al. Demonstration of regulatory cross-talking between P fimbriae and type 1 fimbriae in uropathogenic Escherichia coli. Microbiology 2006; 152: 1143-1153.
23. Fischer H, Yamamoto M, Akira S et al. Mechanism of pathogen-specific TLR4 activation in the mucosa: fimbriae, recognition receptors and adaptor protein selection. Eur J Immunol 2006; 36: 267-277.
24. Hedlund M, Svensson M, Nilsson Å et al. Role of the ceramide signalling pathway in cytokine responses to P fimbriated Escherichia coli. J Exp Med 1996; 183: 1-8.
25. Frendeus B, Wachtler C, Hedlund M et al. Escherichia coli P fimbriae utilize the Toll-like receptor 4 pathway for cell activation. Mol Microbiol 2001; 40: 37-51.
26. Hedlund M, Nilsson A, Duan RD et al. Sphingomyelin, glycosphingolipids and ceramide signalling in cells exposed to P fimbriated Escherichia coli. Mol Microbiol 1998; 29: 1297-1306.
27. Hedlund M, Wachtler C, Johansson E et al. P fimbriae-dependent, lipopolysaccharide-independent activation of epithelial cytokine responses. Mol Microbiol 1999; 33: 693-703.
28. Ganz T. Defensins in the urinary tract and other tissues. J Infect Dis 2001; 183: S41-S42.
29. Chromek M, Slamova Z, Bergman P et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacteria. Nat Med 2006; 12: 636-641.
30. Godaly G, Proudfoot AEI, Offord RE et al. Role of epithelial interleukin-8 and neutrophil IL-8 receptor A in Escherichia coli-induced transuroepithelial neutrophil migration. Infect Immun 1997; 65: 3451-3456.
31. Godaly G, Bergsten G, Hang L et al. Neutrophil recruitment, chemokine receptors, and resistance to mucosal infection. J Leukoc Biol 2001; 69: 899-906.
32. Frendeus B, Godaly G, Hang L et al. Interleukin 8 receptor deficiency confers susceptibility to acute experimental pyelonephritis and may have a human counterpart. J Exp Med 2000; 192: 881-890.
33. Lundstedt AC, Leijonhufvud I, Ragnarsdottir B et al. Inherited susceptibility to acute pyelonephritis: a family study of urinary tract infection. J Infect Dis 2007 (in press).
34. Svanborg-Edén C, Hagberg L, Briles D et al. Susceptibility to Escherichia coli urinary tract infection and LPS responsiveness. In: Skamene E (ed). Genetic Control of Host Resistance to Infection and Malignancy. Alan R. Liss: New York, 1985, pp 385-391.
35. Ragnarsdottir B, Samuelsson M, Karpman D et al. Reduced TLR4 expression in children with asymptomatic bacteriuria. J Infect Dis 2007 (in press).